FACIT (Fight Against Cancer Innovation Trust)
Government fundToronto · Pre-Seed–Series B · 13 people tracked
Investment thesis
FACIT focuses on funding and growing Ontario oncology and health innovation ventures to benefit patients and the provincial economy. Established by the Ontario Institute for Cancer Research (OICR), it supports commercialization, technology transfer and development of cancer research, aiming to attract more R&D investment to Ontario and bring the best oncology innovations to market. Its investments have generated partnerships, clinical trials, job creation and leveraged financing across the province. FACIT also runs a pitch competition (Falcons' Fortunes) and awards, and works alongside OICR to advance cancer solutions that help patients live longer, healthier lives.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 9 of 53 portfolio companiesMedical Devices ×6Biotech ×5Healthtech ×4Deep Tech ×3Data & Infrastructure ×1Digital Health ×1Enterprise Software ×1FemTech ×1
HQs:Canada×1United States×1
Investments · 53 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 22022 · 16 dated
Acquired by Fluidigm/Standard BioTools.
Acquired by Trillium Therapeutics.
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists.
Digital HealthFemTechHealthtechMedical Devices
Rachel Bartholomew(CEO & Founder)Kamyar Rounidej(Former Co-founder & first Chief Technical Officer)
KA Imaging develops X-ray imaging technologies and detectors, including dual-energy radiography and phase contrast micro-CT systems, serving medical, veterinary, scientific research, and industrial quality control markets.
Deep TechHardwareMedical DevicesWaterloo, CA
Vancouver
Caroline Stout(Director)Bernard Lam(Executive Officer)Kamran Alam(Executive Officer)Ulrik Nielsen(Director)Heather Lee(Director)Emily Titus(Executive Officer)
Privacy Analytics provides data privacy and regulatory compliance technology and services for organizations seeking to safely manage and use sensitive personal data.
Data & InfrastructureEnterprise SoftwareHealthtech
QurCan Therapeutics develops nanoparticle drug delivery technology called TERP to create nanomedicines for cancer and central nervous system diseases, with a focus on improving tissue targeting and reducing toxicity associated with existing approaches.
BiotechDeep TechMedical Devices
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.
Deep TechHealthtechMedical Devices
Wayne SchnarrAlla ReznikAndrew DeanCarmel ShieldsPeyvand Melati
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
BiotechNew York, US
Jose Manuel Otero(Executive Officer)Robert Gould(Director)Jane Henderson(Executive Officer)Michael Burgess(Executive Officer)Stefan Larson(Director)Patrick Machado(Director)
BiotechNobleton
Zaid Atto(Executive Officer)
Exits · 2
IPOs and acquisitions across the tracked portfolioDVS Sciencesacq. by Fluidigm Corp.Fluorinov Pharmaacq. by Trillium Therapeutics
Frequently asked questions
- What stage does FACIT (Fight Against Cancer Innovation Trust) invest at?
- FACIT (Fight Against Cancer Innovation Trust) invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is FACIT (Fight Against Cancer Innovation Trust)'s typical check size?
- FACIT (Fight Against Cancer Innovation Trust) typically writes checks of $1.1M.
- What sectors does FACIT (Fight Against Cancer Innovation Trust) focus on?
- FACIT (Fight Against Cancer Innovation Trust) focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is FACIT (Fight Against Cancer Innovation Trust) located?
- FACIT (Fight Against Cancer Innovation Trust) is headquartered in Toronto, CA.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
Pillar VC is an early-stage venture capital firm that partners with technical founders at inception to build companies from breakthrough technology.